Antibody Therapeutics for Life

Notices


No Title Written by Written date Inquire
32   PharmAbcine enters collaboration with MSD focused on clinical evaluation of TTAC-0001 in combination with KEYTRUDA® (pembrolizumab) in recurrent glioblastoma and breast cancer.   Admin   2019-01-14   663  
31   Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.   Admin   2019-01-14   921  
30   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to 36th JP Morgan Healthcare Conference.   Admin   2019-01-14   788  
29   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at Biotech Showcase 2018.   Admin   2019-01-14   784  
28   PharmAbcine Announces Presentation at the 2017 Annual Meeting of the Society of Neuro-Oncology.   Admin   2019-01-14   3,663  
27   Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at the immuno oncology session at PHAR-EAST conference on March 1-2, 2018.   Admin   2019-01-14   799  
26   Dr. Jin-San Yoo, CEO of PharmAbcine is attending and partnering at AusBiotech 2017 at Adelaid Convention Centre South Australia, on 25-27 October 2017.   Admin   2019-01-14   833  
25   PharmAbcine is sponsoring THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.   Admin   2019-01-14   1,932  
24   Dr. Lawrence Cher is presenting Tanibirumab phase IIa interim data at THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.   Admin   2019-01-14   671  
23   Dr. Jin-San Yoo, CEO of PharmAbcine is attending to THE 10TH COGNO ANNUAL SCIENTIFIC MEETINGS (COOPERATIVE TRAILS GROUP FRO NEURO-ONCOLOGY) on Monday 23rd -Tuesday 24th October 2017.   Admin   2019-01-14   659